Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evaluating newborn screening programmes based on dried blood spots: future challenges.

C Dezateux1

  • 1Department of Epidemiology and Public Health, Institute of Child Health, London, UK.

British Medical Bulletin
|June 15, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regional differences in the frequency of the c.985A>G ACADM mutation: findings from a meta-regression of genotyping and screening studies.

Clinical genetics·2013
Same author

Using cohort studies in lifecourse epidemiology.

Public health·2012
Same author

Sex and ethnic differences in the waist circumference of 5-year-old children: findings from the Millennium Cohort Study.

International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity·2010
Same author

Risk factors for rapid weight gain in preschool children: findings from a UK-wide prospective study.

International journal of obesity (2005)·2010
Same author

Rubella seroprevalence in pregnant women in North Thames: estimates based on newborn screening samples.

Journal of medical screening·2009
Same author

Effects of infant feeding practice on weight gain from birth to 3 years.

Archives of disease in childhood·2008
Same journal

Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

British medical bulletin·2026
Same journal

Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

British medical bulletin·2026
Same journal

Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

British medical bulletin·2026
Same journal

Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

British medical bulletin·2026
Same journal

Enhancing bone healing through osteogenic medium components: biological roles, mechanisms, and clinical applications.

British medical bulletin·2026
Same journal

Moral injury in healthcare workers: causes & interventions.

British medical bulletin·2026
See all related articles

Newborn screening programmes for phenylketonuria and congenital hypothyroidism in the UK were based on observational data. Evaluating new screening tests requires robust evidence, ideally from randomized controlled trials, to ensure benefits outweigh harms.

Area of Science:

  • Public Health
  • Genetics
  • Neonatal Medicine

Background:

  • UK national screening programmes for phenylketonuria (1969) and congenital hypothyroidism (1981) were established without randomized controlled trials.
  • Screening effectiveness has been inferred from national disease registers, leading to inconsistent policies and inequitable access for other conditions.
  • Advances in tandem mass spectrometry enable screening for multiple inborn errors of metabolism, necessitating evidence-based evaluation frameworks.

Purpose of the Study:

  • To discuss the challenges in evaluating newborn screening programmes.
  • To explore the evidence required to justify the expansion of newborn screening.
  • To examine the evaluation of medium chain acyl CoA dehydrogenase deficiency screening as a case study.

Main Methods:

Related Experiment Videos

  • Review of historical UK newborn screening programmes.
  • Discussion of evidence-based policy making for screening initiatives.
  • Analysis of challenges in conducting randomized controlled trials for rare diseases.

Main Results:

  • Historical screening decisions relied on observational data, not randomized controlled trials.
  • Current infrastructure allows for expanded screening but lacks a national framework for evaluation.
  • Significant challenges exist in generating robust evidence for new screening tests.

Conclusions:

  • A national framework is needed to guide the introduction and evaluation of new newborn screening programmes.
  • Randomized controlled trials are ideal for evaluating screening benefits versus harms, but often impractical for rare conditions.
  • Prioritizing and developing methods for evaluating new screening initiatives is crucial for public health.